CLDI – calidi biotherapeutics, inc. (US:NASDAQ)
Stock Stats
News
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 [Yahoo! Finance]
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
Research Suggests the Thymus is Critical in Immunotherapy Outcomes [TheStreet.com]
Form 8-K Calidi Biotherapeutics, For: Mar 29
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
Form 10-K Calidi Biotherapeutics, For: Dec 31
Form 8-K Calidi Biotherapeutics, For: Mar 27
Form 8-K Calidi Biotherapeutics, For: Mar 05
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.